These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 18345533)
1. Expanding the scope of MS binding assays to low-affinity markers as exemplified for mGAT1. Zepperitz C; Höfner G; Wanner KT Anal Bioanal Chem; 2008 May; 391(1):309-16. PubMed ID: 18345533 [TBL] [Abstract][Full Text] [Related]
2. Using short columns to speed up LC-MS quantification in MS binding assays. Höfner G; Wanner KT J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1356-64. PubMed ID: 20036623 [TBL] [Abstract][Full Text] [Related]
3. MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1. Zepperitz C; Höfner G; Wanner KT ChemMedChem; 2006 Feb; 1(2):208-17. PubMed ID: 16892353 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of an LC-ESI-MS/MS quantification method for a potential γ-aminobutyric acid transporter 3 (GAT3) marker and its application in preliminary MS binding assays. Polley M; Höfner G; Wanner KT Biomed Chromatogr; 2013 May; 27(5):641-54. PubMed ID: 23225341 [TBL] [Abstract][Full Text] [Related]
5. MS-Based Screening of 5-Substituted Nipecotic Acid Derived Hydrazone Libraries as Ligands of the GABA Transporter 1. Hauke TJ; Höfner G; Wanner KT ChemMedChem; 2019 Mar; 14(5):583-593. PubMed ID: 30663849 [TBL] [Abstract][Full Text] [Related]
6. Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1. Kern FT; Wanner KT ChemMedChem; 2015 Feb; 10(2):396-410. PubMed ID: 25369775 [TBL] [Abstract][Full Text] [Related]
7. Combination of MS Binding Assays and affinity selection mass spectrometry for screening of structurally homogenous libraries as exemplified for a focused oxime library addressing the neuronal GABA transporter 1. Gabriel J; Höfner G; Wanner KT Eur J Med Chem; 2020 Nov; 206():112598. PubMed ID: 32896797 [TBL] [Abstract][Full Text] [Related]
8. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents. Lutz T; Wein T; Höfner G; Wanner KT ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164 [TBL] [Abstract][Full Text] [Related]